Pure Global

A Comparison of Two Nebulisers for Sputum Induction - Trial NCT04182009

Access comprehensive clinical trial information for NCT04182009 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nottingham and is currently status unknown. The study focuses on Asthma,COPD. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT04182009
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT04182009
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Comparison of Two Nebulisers for Sputum Induction
A Comparison of Two Nebulisers for Performing Sputum Induction to Assess Airway Inflammation

Study Focus

Asthma,COPD

Omron NE-U17 Ultrasonic nebuliser

Interventional

device

Sponsor & Location

University of Nottingham

Nottingham, United Kingdom

Timeline & Enrollment

N/A

Sep 17, 2018

Dec 31, 2019

54 participants

Primary Outcome

The tolerability to sputum induction test

Summary

Sputum induction is considered a relatively non-invasive, reliable procedure, which can be
 utilised to characterise the inflammatory profile of the airways.
 
 However, the procedure can be slightly uncomfortable for patients. This study aims to assess
 the differences in participants' tolerability of sputum induction, by comparing two different
 nebulisers when performing the procedure.

ICD-10 Classifications

Asthma
Asthma, unspecified
Nonallergic asthma
Mixed asthma
Other chronic obstructive pulmonary disease

Data Source

ClinicalTrials.gov

NCT04182009

Device Trial